Purple Biotech (PPBT) Return on Assets (2015 - 2026)

Name: Purple Biotech (PPBT) Return on Assets (2015 - 2026) | Business Quant
Creator: Business Quant

Purple Biotech (PPBT) reported Return on Assets of 0.0% for Q1 2026.

Purple Biotech (PPBT) has 1 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY) and the FY2023 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets was little changed at 0.0% in Q1 2026 per PPBT's latest filing.
Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-0.01%
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	0.00%
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-0.01%
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	0.00%
7	Evaxion A	62.56 Bn	62.54 Bn	-	0.00%
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	0.00%
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	0.00%
10	Purple Biotech	3.58 Bn	3.57 Bn	-	0.00%

Download Data 🔒